Population Genetic Analysis of Plasmodium falciparum Parasites Using a Customized Illumina GoldenGate Genotyping Assay

Susana Campino(Wellcome Sanger Institute), Sarah Auburn(Charles Darwin University), Katja Kivinen(Wellcome Sanger Institute), Issaka Zongo(Institut de Recherche en Sciences de la Santé), Jean‐Bosco Ouédraogo(Institut de Recherche en Sciences de la Santé), Valentina Mangano(Sapienza University of Rome), Abdoulaye Djimdé(University of Bamako), Ogobara K. Doumbo(University of Bamako), Steven M. Kiara(Kenya Medical Research Institute), Alexis Nzila(Kenya Medical Research Institute), Steffen Borrmann(Kenya Medical Research Institute), Kevin Marsh(Kenya Medical Research Institute), P Michon(Divine Word University), Ivo Müeller(Divine Word University), Peter Siba(Papua New Guinea Institute of Medical Research), Hongying Jiang(National Institutes of Health), Xin‐zhuan Su(National Institute of Allergy and Infectious Diseases), Chanaki Amaratunga(National Institute of Allergy and Infectious Diseases), Duong Socheat(Cambodia National Malaria Center), Rick M. Fairhurst(National Institutes of Health), Mallika Imwong(Mahidol Oxford Tropical Medicine Research Unit), Timothy J. C. Anderson(Texas Biomedical Research Institute), François Nosten(Shoklo Malaria Research Unit), Nicholas J. White(Mahidol Oxford Tropical Medicine Research Unit), Rhian Gwilliam(Wellcome Sanger Institute), Panos Deloukas(Wellcome Sanger Institute), Bronwyn MacInnis(Wellcome Sanger Institute), Chris Newbold(John Radcliffe Hospital), Kirk A. Rockett(Centre for Human Genetics), Taane G. Clark(London School of Hygiene & Tropical Medicine), Dominic Kwiatkowski(University of Oxford)
PLoS ONE
June 6, 2011
Cited by 52Open Access
Full Text

Abstract

The diversity in the Plasmodium falciparum genome can be used to explore parasite population dynamics, with practical applications to malaria control. The ability to identify the geographic origin and trace the migratory patterns of parasites with clinically important phenotypes such as drug resistance is particularly relevant. With increasing single-nucleotide polymorphism (SNP) discovery from ongoing Plasmodium genome sequencing projects, a demand for high SNP and sample throughput genotyping platforms for large-scale population genetic studies is required. Low parasitaemias and multiple clone infections present a number of challenges to genotyping P. falciparum. We addressed some of these issues using a custom 384-SNP Illumina GoldenGate assay on P. falciparum DNA from laboratory clones (long-term cultured adapted parasite clones), short-term cultured parasite isolates and clinical (non-cultured isolates) samples from East and West Africa, Southeast Asia and Oceania. Eighty percent of the SNPs (n = 306) produced reliable genotype calls on samples containing as little as 2 ng of total genomic DNA and on whole genome amplified DNA. Analysis of artificial mixtures of laboratory clones demonstrated high genotype calling specificity and moderate sensitivity to call minor frequency alleles. Clear resolution of geographically distinct populations was demonstrated using Principal Components Analysis (PCA), and global patterns of population genetic diversity were consistent with previous reports. These results validate the utility of the platform in performing population genetic studies of P. falciparum.


Related Papers

No related papers found

Powered by citation graph analysis